David Holland - Alimera Sciences Insider

ALIM -- USA Stock  

USD 1.08  0.04  3.85%

Co-Founder and Sr. VP of Sales and Marketing
Mr. David R. Holland is the Senior Vice President Sales and Marketing of Alimera Sciences, Inc. Prior cofounders and served as the Vice President of Marketing since the founding of our Company in 2003 through August 2010 when he was appointed the Senior Vice President of Sales and Marketing. Prior to founding our Company, Mr. Holland served as the Vice President of Marketing of Novartis Ophthalmics from 1998 to 2003. In 1997, Mr. Holland served as Global Head of the Lens Business at CIBA Vision and in 1996, Global Head of the Lens Care Business of CIBA Vision. From 1992 to 1995, Mr. Holland served as the Director of Marketing for CIBA Vision Ophthalmics. From 1989 to 1991, Mr. Holland served as New Products Manager for CIBA Vision. From 1985 to 1989, Mr. Holland served as a Brand Assistant and Assistant Brand Manager of Procter and Gamble. Mr. Holland holds an A.B. in Politics from Princeton University.
Age: 51  Founder Since 2010      
678-990-5740  http://www.alimerasciences.com

David Holland Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (16.54) % which means that it has lost $16.54 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (160.39) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 37.75 M in liabilities with Debt to Equity (D/E) ratio of 441.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Alimera Sciences has Current Ratio of 4.7 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. Alimera Sciences, Inc. was founded in 2003 and is headquartered in Alpharetta, Georgia. Alimera Sciences operates under Drug Manufacturers - Major classification in USA and traded on NASDAQ General Markets. It employs 118 people.Alimera Sciences (ALIM) is traded on BATS Exchange in USA. It is located in GEORGIA U.S.A and employs 118 people. Alimera Sciences is listed under Pharmaceutical Products category by Fama And French industry classification.

Alimera Sciences Leadership Team

James Largent, Director, MBA
Peter Pizzo, Director, Ph.D
Calvin Roberts, Director, Ph.D
Mary Szela, Director, MBA
David Burke, President
Philip Ashman, Managing Director, Ph.D
David Holland, Founder
Kenneth Green, SVP, Ph.D
Richard Eiswirth, CFO
Brian Halak, Director, Ph.D
Daniel Myers, CEO
Mark Brooks, Director, MBA
Rich Cockrell, President

Stock Performance Indicators

Did you try this?

Run Risk-Return Analysis Now
   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Risk-Return Analysis

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Alimera Sciences and AstraZeneca PLC. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.